CIS
ONC

Capital International Sarl’s BeOne Medicines Ltd ONC Stock Holding History

Capital International Sarl’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50M Buy
175,542
+1,663
+1% +$490K 0.71% 37
2026
Q1 		$51.6M Buy
173,879
+21,364
+14% +$6.92M 0.85% 32
2025
Q4 		$46.3M Buy
152,515
+3,956
+3% +$1.29M 0.74% 40
2025
Q3 		$50.6M Buy
148,559
+14,635
+11% +$4.44M 0.87% 29
2025
Q2 		$32.4M Sell
133,924
-5,081
-4% -$1.25M 0.62% 48
2025
Q1 		$37.8M Sell
139,005
-13,705
-9% -$3.2M 0.86% 32
2024
Q4 		$28.2M Buy
152,710
+968
+0.6% +$198K 0.65% 41
2024
Q3 		$34.1M Sell
151,742
-40,683
-21% -$7.32M 0.88% 32
2024
Q2 		$27.5M Buy
192,425
+483
+0.3% +$74.4K 0.84% 32
2024
Q1 		$30M Buy
191,942
+15,605
+9% +$2.51M 1% 27
2023
Q4 		$31.8M Buy
176,337
+10,792
+7% +$1.95M 1.19% 17
2023
Q3 		$29.8M Sell
165,545
-4,042
-2% -$800K 1.36% 11
2023
Q2 		$30.2M Buy
169,587
+16,630
+11% +$3.83M 1.36% 10
2023
Q1 		$33M Buy
152,957
+24,576
+19% +$5.89M 1.66% 5
2022
Q4 		$28.2M Buy
128,381
+4,628
+4% +$849K 1.99% 6
2022
Q3 		$16.7M Sell
123,753
-2,412
-2% -$414K 1.35% 12
2022
Q2 		$20.4M Sell
126,165
-46,807
-27% -$7.31M 1.64% 11
2022
Q1 		$32.6M Buy
172,972
+47,918
+38% +$10.2M 1.62% 7
2021
Q4 		$33.9M Buy
125,054
+19,717
+19% +$6.66M 1.62% 8
2021
Q3 		$38.2M Buy
105,337
+7,283
+7% +$2.38M 3.38% 1
2021
Q2 		$33.7M Sell
98,054
-1,209
-1% -$400K 2.91% 2
2021
Q1 		$34.6M Sell
99,263
-3,513
-3% -$1.16M 3.3% 1
2020
Q4 		$26.6M Sell
102,776
-335
-0.3% -$92.2K 2.77% 3
2020
Q3 		$29.5M Sell
103,111
-1,176
-1% -$276K 3.62% 1
2020
Q2 		$19.6M Buy
104,287
+1,011
+1% +$165K 2.61% 3
2020
Q1 		$12.7M Buy
103,276
+16,833
+19% +$2.63M 2.31% 6
2019
Q4 		$14.3M Sell
86,443
-29,782
-26% -$4.95M 2.22% 5
2019
Q3 		$14.2M Buy
116,225
+1,625
+1% +$216K 2.45% 7
2019
Q2 		$14.2M Buy
114,600
+9,700
+9% +$1.23M 1.98% 10
2019
Q1 		$13.8M Buy
104,900
+37,600
+56% +$5.07M 1.73% 11
2018
Q4 		$9.44M Buy
+67,300
New +$8.92M 1.14% 29

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Capital International Sarl's ONC Position: Q2 2026 in Review

Capital International Sarl increased its BeOne Medicines Ltd (ONC) stake by 0.96% in Q2 2026, buying an estimated $490K and bringing the position to 175,542 shares worth $50M. The position accounts for 0.71% of the portfolio, ranked #37.

Capital International Sarl first reported a position in ONC in Q4 2018 and has held it in 31 quarters since. The position peaked at $51.6M in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Capital International Sarl held 175,542 shares of BeOne Medicines Ltd worth $50M as of Q2 2026.
  • Capital International Sarl bought 1,663 BeOne Medicines Ltd shares in Q2 2026, an estimated $490K.
  • BeOne Medicines Ltd made up 0.71% of Capital International Sarl's portfolio in Q2 2026, its #37 holding.
  • Capital International Sarl first reported a position in BeOne Medicines Ltd in Q4 2018 and has held it in 31 quarters since.
  • Capital International Sarl's BeOne Medicines Ltd position peaked at $51.6M in Q1 2026.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Capital International Sarl's 13F filing for Q2 2026, filed 12 Aug 2026.